United States Biotechnology & Medical Research

Ardelyx Inc (ARDX)

Track

Over the past 90 days, Ardelyx Inc. insiders have executed 35 transactions, resulting in a net negative value of approximately $534,448. All activity consisted of sales, including planned and proposed divestments by executives such as CEO Michael Raab and Chief Patient Officer Laura Williams. These transactions occurred amid a 32.2% decline in stock price.
Ticker: ARDX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Ardelyx Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 15 Jul 2026
Value US$2,472,796.73 | Price 331.40 | Shares 1,819 (-11.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-17 2026-07-15 PlS Planned sale
3.1
RAAB MICHAEL

President & CEO

Executive Director
1,819 -11.5%
331.40
US$2,472,797 		1,819 -11.5% 331.40 US$2,472,797
2026-06-22 2026-06-18 PlS Planned sale
3.8
Williams Laura A

Chief Patient Officer

Officer
94,817 +39.1%
79.43
US$1,488,019 		94,817 +39.1% 79.43 US$1,488,019
2026-06-22 2026-06-18 PlS Planned sale
3.8
Williams Laura A

Chief Patient Officer

Officer
10,856 +37.3%
310.14
US$2,195,627 		10,856 +37.3% 310.14 US$2,195,627
2026-06-18 2026-06-18 PrS Proposed sale
3.8
LAURA WILLIAMS

Officer

Officer
81,898
5.84
US$478,284 		81,898 5.84 US$478,284
2026-06-17 2026-06-15 PlS Planned sale
3.1
RAAB MICHAEL

President & CEO

Executive Director
41,666 -2.4%
5.67
US$236,346 		41,666 -2.4% 5.67 US$236,346
2026-06-17 2026-06-15 PrS Proposed sale
3.1
RAAB MICHAEL

Officer; Director

Executive Director
41,666
5.68
US$236,663 		41,666 5.68 US$236,663
2026-06-15 2026-06-15 PrS Proposed sale
3.1
MICHAEL RAAB

Director; Officer

Executive Director
125,000
5.69
US$711,250 		125,000 5.69 US$711,250
2026-05-22 2026-05-21 S Sale
2.5
Foster Eric Duane

Chief Commercial Officer

Officer
2,405 -0.6%
6.27
US$15,073 		2,405 -0.6% 6.27 US$15,073
2026-05-22 2026-05-21 S Sale
2.5
Foster Eric Duane

Chief Commercial Officer

Officer
2,427 -0.6%
6.27
US$15,211 		2,427 -0.6% 6.27 US$15,211
2026-05-22 2026-05-21 S Sale
2.5
Foster Eric Duane

Chief Commercial Officer

Officer
3,166 -0.7%
6.27
US$19,843 		3,166 -0.7% 6.27 US$19,843
2026-05-22 2026-05-21 S Sale
3.1
RAAB MICHAEL

President & CEO

Executive Director
14,028 -0.8%
6.27
US$87,920 		14,028 -0.8% 6.27 US$87,920
2026-05-22 2026-05-21 S Sale
3.1
RAAB MICHAEL

President & CEO

Executive Director
17,926 -1.0%
6.27
US$112,351 		17,926 -1.0% 6.27 US$112,351
2026-05-22 2026-05-21 S Sale
3.1
RAAB MICHAEL

President & CEO

Executive Director
7,861 -0.4%
6.27
US$49,269 		7,861 -0.4% 6.27 US$49,269
2026-05-22 2026-05-21 S Sale
3.1
RAAB MICHAEL

President & CEO

Executive Director
14,933 -0.8%
6.27
US$93,593 		14,933 -0.8% 6.27 US$93,593
2026-05-22 2026-05-21 S Sale
2.4
Kelliher Mike

Chief Business Officer

Officer
2,478 -0.7%
6.27
US$15,531 		2,478 -0.7% 6.27 US$15,531
2026-05-22 2026-05-21 S Sale
2.4
Kelliher Mike

Chief Business Officer

Officer
1,870 -0.5%
6.27
US$11,720 		1,870 -0.5% 6.27 US$11,720
2026-05-22 2026-05-21 S Sale
2.4
Kelliher Mike

Chief Business Officer

Officer
2,900 -0.8%
6.27
US$18,176 		2,900 -0.8% 6.27 US$18,176
2026-05-22 2026-05-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
1,418 -0.3%
6.27
US$8,887 		1,418 -0.3% 6.27 US$8,887
2026-05-22 2026-05-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
1,911 -0.4%
6.27
US$11,977 		1,911 -0.4% 6.27 US$11,977
2026-05-22 2026-05-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
2,157 -0.5%
6.27
US$13,519 		2,157 -0.5% 6.27 US$13,519
2026-05-22 2026-05-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
1,503 -0.3%
6.27
US$9,420 		1,503 -0.3% 6.27 US$9,420
2026-05-22 2026-05-21 S Sale
1.5
Hohenleitner Susan

Chief Financial Officer

Officer
1,455 -0.6%
6.27
US$9,119 		1,455 -0.6% 6.27 US$9,119
2026-05-22 2026-05-21 S Sale
1.5
Brady James Parker

Chief Human Resources Officer

Officer
1,846 -0.7%
6.27
US$11,570 		1,846 -0.7% 6.27 US$11,570
2026-05-22 2026-05-21 PlS Planned sale
1.9
Reilly Joseph James

See Remarks

Officer
1,036 -0.7%
6.27
US$6,493 		1,036 -0.7% 6.27 US$6,493
2026-05-22 2026-05-21 S Sale
1.9
Reilly Joseph James

See Remarks

Officer
2,683 -1.8%
6.27
US$16,816 		2,683 -1.8% 6.27 US$16,816
2026-05-22 2026-05-21 S Sale
1.5
Bishop John E

See Remarks

Officer
2,306 -0.7%
6.27
US$14,453 		2,306 -0.7% 6.27 US$14,453
2026-05-19 2026-05-19 PrS Proposed sale
2.4
Kelliher Mike

Officer

Officer
10,500
6.23
US$65,415 		10,500 6.23 US$65,415
2026-05-19 2026-05-19 PrS Proposed sale
1.5
Brady James Parker

Officer

Officer
3,000
6.23
US$18,690 		3,000 6.23 US$18,690
2026-05-19 2026-05-19 PrS Proposed sale
2.5
Foster Eric Duane

Officer

Officer
11,900
6.23
US$74,137 		11,900 6.23 US$74,137
2026-05-19 2026-05-19 PrS Proposed sale
1.9
Reilly Joseph James

Officer

Officer
4,700
6.23
US$29,281 		4,700 6.23 US$29,281
2026-05-19 2026-05-19 PrS Proposed sale
1.5
Hohenleitner Susan

Officer

Officer
2,650
6.23
US$16,510 		2,650 6.23 US$16,510
2026-05-19 2026-05-19 PrS Proposed sale
3.8
Williams Laura A

Officer

Officer
10,500
6.23
US$65,415 		10,500 6.23 US$65,415
2026-05-19 2026-05-19 PrS Proposed sale
3.1
RAAB MICHAEL

Officer

Officer
44,500
6.23
US$277,235 		44,500 6.23 US$277,235
2026-05-19 2026-05-19 PrS Proposed sale
1.5
Bishop John E

Officer

Officer
3,700
6.23
US$23,051 		3,700 6.23 US$23,051
2026-05-19 2026-05-15 PlS Planned sale
3.1
RAAB MICHAEL

President & CEO

Executive Director
41,666 -2.3%
6.28
US$261,612 		41,666 -2.3% 6.28 US$261,612
2026-04-17 2026-04-15 PlS Planned sale
3.1
RAAB MICHAEL

President & CEO

Executive Director
41,668 -2.3%
6.29
US$261,954 		41,668 -2.3% 6.29 US$261,954
2026-03-18 2026-03-16 PlS Planned sale
3.1
RAAB MICHAEL

President & CEO

Executive Director
41,666 -2.2%
5.84
US$243,329 		41,666 -2.2% 5.84 US$243,329
2026-02-25 2026-02-24 PlS Planned sale
3.1
RAAB MICHAEL

President & CEO

Executive Director
41,666 -2.2%
6.26
US$260,621 		41,666 -2.2% 6.26 US$260,621
2026-02-24 2026-02-24 PrS Proposed sale
3.1
MICHAEL RAAB

Director; Officer

Executive Director
166,666
5.75
US$958,330 		166,666 5.75 US$958,330
2026-02-23 2026-02-20 B Purchase
4.0
MOTT DAVID M
Non-Executive Director
333,333 +11.2%
5.84
US$1,946,331 		333,333 +11.2% 5.84 US$1,946,331
2026-02-23 2026-02-20 S Sale
1.9
Reilly Joseph James

See Remarks

Officer
2 -0.0%
5.70
US$11 		2 -0.0% 5.70 US$11
2026-02-23 2026-02-20 S Sale
1.9
Reilly Joseph James

See Remarks

Officer
602 -0.4%
5.71
US$3,440 		602 -0.4% 5.71 US$3,440
2026-02-23 2026-02-20 S Sale
1.9
Reilly Joseph James

See Remarks

Officer
4,387 -2.8%
5.87
US$25,730 		4,387 -2.8% 5.87 US$25,730
2026-02-23 2026-02-20 S Sale
1.5
Bishop John E

See Remarks

Officer
1 -0.0%
5.70
US$6 		1 -0.0% 5.70 US$6
2026-02-23 2026-02-20 S Sale
1.5
Bishop John E

See Remarks

Officer
386 -0.1%
5.71
US$2,206 		386 -0.1% 5.71 US$2,206
2026-02-23 2026-02-20 S Sale
1.5
Bishop John E

See Remarks

Officer
2,792 -0.8%
5.87
US$16,375 		2,792 -0.8% 5.87 US$16,375
2026-02-23 2026-02-20 S Sale
3.8
Williams Laura A

See Remarks

Officer
984 -0.2%
5.71
US$5,622 		984 -0.2% 5.71 US$5,622
2026-02-23 2026-02-20 S Sale
3.8
Williams Laura A

See Remarks

Officer
7,192 -1.6%
5.87
US$42,181 		7,192 -1.6% 5.87 US$42,181
2026-02-23 2026-02-20 S Sale
1.5
Hohenleitner Susan

Chief Financial Officer

Officer
247 -0.1%
5.71
US$1,411 		247 -0.1% 5.71 US$1,411
2026-02-23 2026-02-20 S Sale
1.5
Hohenleitner Susan

Chief Financial Officer

Officer
1,786 -0.8%
5.87
US$10,475 		1,786 -0.8% 5.87 US$10,475
2026-02-23 2026-02-20 S Sale
2.4
Kelliher Mike

See Remarks

Officer
2 -0.0%
5.71
US$11 		2 -0.0% 5.71 US$11
2026-02-23 2026-02-20 S Sale
2.4
Kelliher Mike

See Remarks

Officer
1,159 -0.3%
5.71
US$6,622 		1,159 -0.3% 5.71 US$6,622
2026-02-23 2026-02-20 S Sale
2.4
Kelliher Mike

See Remarks

Officer
8,434 -2.3%
5.87
US$49,465 		8,434 -2.3% 5.87 US$49,465
2026-02-23 2026-02-20 S Sale
1.5
Brady James Parker

Chief Human Resources Officer

Officer
309 -0.1%
5.71
US$1,766 		309 -0.1% 5.71 US$1,766
2026-02-23 2026-02-20 S Sale
1.5
Brady James Parker

Chief Human Resources Officer

Officer
2,234 -0.8%
5.87
US$13,102 		2,234 -0.8% 5.87 US$13,102
2026-02-23 2026-02-20 S Sale
3.1
RAAB MICHAEL

President & CEO

Executive Director
2 -0.0%
5.70
US$11 		2 -0.0% 5.70 US$11
2026-02-23 2026-02-20 S Sale
3.1
RAAB MICHAEL

President & CEO

Executive Director
1 -0.0%
5.70
US$6 		1 -0.0% 5.70 US$6
2026-02-23 2026-02-20 S Sale
3.1
RAAB MICHAEL

President & CEO

Executive Director
2 -0.0%
5.70
US$11 		2 -0.0% 5.70 US$11
2026-02-23 2026-02-20 S Sale
3.1
RAAB MICHAEL

President & CEO

Executive Director
5,576 -0.3%
5.71
US$31,860 		5,576 -0.3% 5.71 US$31,860
2026-02-23 2026-02-20 S Sale
3.1
RAAB MICHAEL

President & CEO

Executive Director
40,401 -2.1%
5.87
US$236,952 		40,401 -2.1% 5.87 US$236,952
2026-02-23 2026-02-20 S Sale
2.5
Foster Eric Duane

Chief Commercial Officer

Officer
1 -0.0%
5.70
US$6 		1 -0.0% 5.70 US$6
2026-02-23 2026-02-20 S Sale
2.5
Foster Eric Duane

Chief Commercial Officer

Officer
1 -0.0%
5.71
US$6 		1 -0.0% 5.71 US$6
2026-02-23 2026-02-20 S Sale
2.5
Foster Eric Duane

Chief Commercial Officer

Officer
1,261 -0.3%
5.71
US$7,205 		1,261 -0.3% 5.71 US$7,205
2026-02-23 2026-02-20 S Sale
2.5
Foster Eric Duane

Chief Commercial Officer

Officer
9,176 -2.1%
5.87
US$53,817 		9,176 -2.1% 5.87 US$53,817
2026-02-23 2026-02-20 PrS Proposed sale
1.9
Reilly Joseph James

Officer

Officer
4,991
6.72
US$33,540 		4,991 6.72 US$33,540
2026-02-20 2026-02-20 PrS Proposed sale
3.8
Williams Laura A

Officer

Officer
11,300
5.73
US$64,749 		11,300 5.73 US$64,749
2026-02-20 2026-02-20 PrS Proposed sale
2.4
Kelliher Mike

Officer

Officer
11,800
5.73
US$67,614 		11,800 5.73 US$67,614
2026-02-20 2026-02-20 PrS Proposed sale
1.9
Reilly Joseph James

Officer

Officer
4,900
5.73
US$28,077 		4,900 5.73 US$28,077
2026-02-20 2026-02-20 PrS Proposed sale
2.5
Foster Eric Duane

Officer

Officer
13,350
5.73
US$76,496 		13,350 5.73 US$76,496
2026-02-20 2026-02-20 PrS Proposed sale
3.1
RAAB MICHAEL

Officer

Officer
51,100
5.73
US$292,803 		51,100 5.73 US$292,803
2026-02-20 2026-02-20 PrS Proposed sale
1.5
Hohenleitner Susan

Officer

Officer
2,550
5.73
US$14,612 		2,550 5.73 US$14,612
2026-02-20 2026-02-20 PrS Proposed sale
1.5
Bishop John E

Officer

Officer
3,700
5.73
US$21,201 		3,700 5.73 US$21,201
2026-02-20 2026-02-20 PrS Proposed sale
1.5
Brady James Parker

Officer

Officer
3,000
5.73
US$17,190 		3,000 5.73 US$17,190
2026-01-09 2026-01-08 PlS Planned sale
3.8
Williams Laura A

Chief Patient Officer

Officer
50,000 -12.1%
6.98
US$348,900 		50,000 -12.1% 6.98 US$348,900
2026-01-08 2026-01-08 PrS Proposed sale
3.8
LAURA A WILLIAMS

Officer

Officer
50,000
5.83
US$291,500 		50,000 5.83 US$291,500
Explore more

More insider trading research around Ardelyx Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America